TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
EW

Edwards Lifesciences Corp

Healthcare · Medical Devices

87.20$ +2.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Edwards Lifesciences Corp (EW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 13,697 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EW
Line item 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1,437 1,088 973 1,008 1,101 1,113 1,229 1,247 1,345 1,400 1,616 1,767 1,981 2,222 2,725 3,524 4,059 4,510 5,697 5,324 6,488 7,237 8,503 8,293 9,363 13,055 13,697
356 282 293 326 360 368 514 532 582 692 889 1,033 1,169 1,292 1,726 2,295 2,048 2,240 2,532 2,287 2,984 3,091 3,181 3,096 4,036 6,285 6,739
– 28 48 34 61 49 179 183 142 219 334 396 171 311 420 654 718 930 818 714 1,179 1,183 863 769 1,132 3,045 2,939
13 28 48 34 61 49 179 183 191 227 334 396 451 521 937 1,439 1,225 1,271 1,338 957 1,517 1,403 1,467 1,215 1,633 3,976 4,227
155 129 101 108 119 119 119 127 145 205 272 303 321 348 328 325 344 415 479 537 599 603 665 699 828 727 912
169 73 87 112 121 128 132 142 153 152 166 204 261 281 309 297 340 397 555 607 641 802 727 876 904 1,087 1,126
– 183 178 209 210 202 202 213 228 230 252 270 304 373 422 443 483 580 680 868 1,060 1,395 1,639 1,725 1,843 1,784 1,915
839 511 402 334 338 338 338 338 350 316 315 315 350 385 385 376 628 626 1,127 1,112 1,168 1,173 1,168 1,164 1,145 1,777 1,769
155 511 402 399 419 490 138 116 123 97 87 67 67 67 34 23 205 205 468 343 337 331 324 285 399 1,177 1,128
213 648 514 469 466 485 539 497 510 521 458 459 643 742 1,166 1,333 1,556 1,891 2,702 2,183 2,340 2,663 2,667 2,486 2,644 2,992 3,360
156 219 184 198 167 195 194 226 375 259 291 338 335 347 346 434 476 533 1,399 877 902 894 1,032 1,022 1,195 1,505 1,814
– 61 1.1 – – – – – 150 – – 42 – – – 598 597 822 598 0.0 26 27 26 26 23 23 25
– 177 184 177 167 195 194 57 64 66 51 48 85 75 48 58 64 97 117 134 180 197 205 202 187 197 228
– 367 310 246 256 267 316 236 62 176 90 0.0 150 189 593 598 597 822 438 594 594 595 596 596 597 598 598
1,224 440 459 539 635 628 690 749 835 879 1,158 1,308 1,338 1,479 1,559 2,191 2,503 2,619 2,995 3,140 4,148 4,574 5,836 5,807 6,650 9,998 10,338
418 103 88 143 222 224 303 434 549 677 906 1,124 1,361 1,654 2,046 2,842 3,337 3,906 2,001 2,695 3,742 4,565 6,068 7,590 8,992 13,167 14,241
697 697 707 736 733 744 748 767 752 715 704 715 716 710 683 651 661 653 648 641 637 632 631 624 609 599 586

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?